Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -
Please visit our MS learning channel on YouTube, which provides hundreds of MS videos presented by MS Experts across the USA, from many of our recorded education programs. Archived here: www.youtube.com/msviewsandnews -- Additionally, please visit our Social media platforms: Facebook, Twitter, and Instagram
Important Resources for the MS community are found on the left side of this blog.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Friday, October 5, 2012
Multiple Sclerosis (MS) specialty drug treatment cost projected to exceed $50,000 per person per year in 2016
Thursday, October 4, 2012
- A "clinically isolated syndrome." These are actual physical symptoms associated with multiple sclerosis that last at least 24 hours. This might be as dramatic as Williamson’s paralysis, or could be more subtle, like persistent numbness in one arm or leg, or a sudden loss of vision in one eye (known as optic neuritis).
- Evidence of lesions on the brain. MS lesions are usually detected using magnetic resonance imaging. These lesions are caused when inflammation leads to the loss of myelin, the protective substance that insulates nerves in the brain and spinal cord.
Which MS Treatment to Choose?
WebMD Health News
Wednesday, October 3, 2012
Tuesday, October 2, 2012
- Aetna medical insurance is considering no longer paying for the ACTHAR Gel for Multiple Sclerosis
- Aetna is trying to prevent an FDA approved medication from being used by MS patients
If true, it might be a useful tool to measure the effectiveness of treatmentsOctober 1, 2012
Monday, October 1, 2012
September 30, 2012